Increased ACE2, sRAGE, and Immune Activation, but Lowered Calciumand Magnesium in COVID-19

Hussein Kadhem Al‐Hakeim, Hawraa Kadhem Al-Jassas, Gerwyn Morris, Michael Maes

Recent Advances in Inflammation & Allergy Drug Discovery · 2022 · 15 citations · 78 references

Abstract

The results show that immune-inflammatory and RAGE pathways biomarkers may be used as an external validating criterion for the diagnosis of COVID-19. Those pathways coupled with lowered SpO2, calcium, and magnesium are drug targets that may help reduce the consequences of COVID-19.

References

78